Mutual Fund Details

Mirae Asset Healthcare Fund Direct - Growth

Name: Mirae Asset Healthcare Fund Direct - Growth
Brand: Mirae Asset Mutual Fund

Equity Pharma

NAV

₹37.2570

as on 03 Mar 2025, 11:17 PM

₹0.1280(0.34%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 18 Nov 2024

DSP Healthcare Fund Direct - Growth

26.66%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

27.62%

Mirae Asset Healthcare Fund Direct - Growth

25.85%

SBI Healthcare Opportunities Fund Direct Plan-Growth

26.28%

UTI Healthcare Fund Direct-Growth

24.73%

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,56,326

₹1,63,477

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹63,477

Profit (absolute return)

63.48%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

11.53%

In the last 6 months

12.93%

In the last 1 year

10.09%

In the last 3 years

63.48%

In the last 5 years

216.07%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Mirae Asset Healthcare Fund Direct - Growth

as of 31 Jan 2025, 05:30 AM

₹2,652.24 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 1 year.

0.47%

Expense Ratio

Plan

Growth

0.16%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 1 year.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Sector

Healthcare

97.42%

₹2,583.88 Cr

Services

0.94%

₹24.81 Cr

Chemicals

0.74%

₹19.62 Cr

Diversified

0.73%

₹19.42 Cr

Others

0.17%

₹4.51 Cr

Sectors Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Sector

Healthcare

97.42%

₹2,583.88 Cr

Services

0.94%

₹24.81 Cr

Chemicals

0.74%

₹19.62 Cr

Diversified

0.73%

₹19.42 Cr

Others

0.17%

₹4.51 Cr

Companies Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.90%

₹342.14 Cr

Cipla Ltd.

9.49%

₹251.70 Cr

Aurobindo Pharma Ltd.

9.34%

₹247.72 Cr

Dr. Reddy's Laboratories Ltd.

7.44%

₹197.33 Cr

Apollo Hospitals Enterprise Ltd.

6.11%

₹162.05 Cr

Others

54.72%

₹1,451.30 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Jan 2025

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.90%

₹342.14 Cr

Cipla Ltd.

9.49%

₹251.70 Cr

Aurobindo Pharma Ltd.

9.34%

₹247.72 Cr

Dr. Reddy's Laboratories Ltd.

7.44%

₹197.33 Cr

Apollo Hospitals Enterprise Ltd.

6.11%

₹162.05 Cr

Others

54.72%

₹1,451.30 Cr

View All

Funds in this Category

This fund's returns:

17.78%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

DSP Healthcare Fund Direct - Growth

About Mirae Asset Healthcare Fund Direct - Growth

Mirae Asset Healthcare Fund Direct - Growth is a Equity mutual fund scheme from Mirae Asset Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹2,652.24 Crores and the latest NAV decalared is ₹37.257 as on 04 Mar 2025 at 3:55 am.

Mirae Asset Healthcare Fund Direct - Growth scheme return performance in last 1 year is 10.09%, in last 3 years is 63.48% and 269.08% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.